Literature DB >> 33033068

Reduced COVID-19 Mortality With Sitagliptin Treatment? Weighing the Dissemination of Potentially Lifesaving Findings Against the Assurance of High Scientific Standards.

Michael A Nauck1, Juris J Meier2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33033068     DOI： 10.2337/dci20-0062

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  17 in total

1.  Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis.

Authors:  Rimesh Pal; Mainak Banerjee; Soham Mukherjee; Ranjitpal Singh Bhogal; Amanpreet Kaur; Sanjay K Bhadada
Journal:  Ther Adv Endocrinol Metab       Date:  2021-02-20       Impact factor: 3.565

Review 2.  Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature.

Authors:  Awadhesh Kumar Singh; Ritu Singh; Banshi Saboo; Anoop Misra
Journal:  Diabetes Metab Syndr       Date:  2020-12-15

3.  Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis.

Authors:  B M Bonora; A Avogaro; G P Fadini
Journal:  J Endocrinol Invest       Date:  2021-01-29       Impact factor: 4.256

4.  Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study.

Authors:  Ronan Roussel; Patrice Darmon; Matthieu Pichelin; Thomas Goronflot; Yawa Abouleka; Leila Ait Bachir; Ingrid Allix; Deborah Ancelle; Sara Barraud; Lyse Bordier; Aurélie Carlier; Nicolas Chevalier; Christine Coffin-Boutreux; Emmanuel Cosson; Anne Dorange; Olivier Dupuy; Pierre Fontaine; Bénédicte Fremy; Florence Galtier; Natacha Germain; Anne-Marie Guedj; Etienne Larger; Stéphanie Laugier-Robiolle; Bruno Laviolle; Lisa Ludwig; Arnaud Monier; Nathanaëlle Montanier; Philippe Moulin; Isabelle Moura; Gaëtan Prevost; Yves Reznik; Nadia Sabbah; Pierre-Jean Saulnier; Pierre Serusclat; Camille Vatier; Matthieu Wargny; Samy Hadjadj; Pierre Gourdy; Bertrand Cariou
Journal:  Diabetes Obes Metab       Date:  2021-02-16       Impact factor: 6.408

5.  Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities.

Authors:  Jonathan D Geiger; Nabab Khan; Madhuvika Murugan; Detlev Boison
Journal:  Front Pharmacol       Date:  2020-11-26       Impact factor: 5.810

6.  Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong.

Authors:  Carlos K H Wong; David T W Lui; Angel Y C Lui; Ashley C Y Kwok; Marshall C H Low; Kristy T K Lau; Ivan C H Au; Xi Xiong; Matthew S H Chung; Eric H Y Lau; Benjamin J Cowling
Journal:  Diabetes Metab       Date:  2021-12-01       Impact factor: 6.041

Review 7.  The enzymes in COVID-19: A review.

Authors:  Maria Helena Menezes Estevam Alves; Layla Carvalho Mahnke; Tifany Cerqueira Macedo; Thais Ketinly Dos Santos Silva; Luiz Bezerra Carvalho Junior
Journal:  Biochimie       Date:  2022-01-26       Impact factor: 4.372

8.  Effect of linagliptin plus insulin in comparison to insulin alone on metabolic control and prognosis in hospitalized patients with SARS-CoV-2 infection.

Authors:  Rodolfo Guardado-Mendoza; Miguel Angel Garcia-Magaña; Liz Jovanna Martínez-Navarro; Hilda Elizabeth Macías-Cervantes; Rodolfo Aguilar-Guerrero; Erick L Suárez-Pérez; Alberto Aguilar-García
Journal:  Sci Rep       Date:  2022-01-11       Impact factor: 4.379

Review 9.  Narrative review on clinical considerations for patients with diabetes and COVID-19: More questions than answers.

Authors:  Niki Katsiki; Ricardo Gómez-Huelgas; Dimitri P Mikhailidis; Pablo Pérez-Martínez
Journal:  Int J Clin Pract       Date:  2021-09-21       Impact factor: 2.503

10.  Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.

Authors:  Anna R Kahkoska; Trine Julie Abrahamsen; G Caleb Alexander; Tellen D Bennett; Christopher G Chute; Melissa A Haendel; Klara R Klein; Hemalkumar Mehta; Joshua D Miller; Richard A Moffitt; Til Stürmer; Kajsa Kvist; John B Buse
Journal:  Diabetes Care       Date:  2021-06-16       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.